Your browser doesn't support javascript.
loading
Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in Portugal.
Borges, Vítor; Duque, Mariana Perez; Martins, João Vieira; Vasconcelos, Paula; Ferreira, Rita; Sobral, Daniel; Pelerito, Ana; de Carvalho, Isabel Lopes; Núncio, Maria Sofia; Borrego, Maria José; Roemer, Cornelius; Neher, Richard A; O'Driscoll, Megan; Rocha, Raquel; Lopo, Sílvia; Neves, Raquel; Palminha, Paula; Coelho, Luís; Nunes, Alexandra; Isidro, Joana; Pinto, Miguel; Santos, João Dourado; Mixão, Verónica; Santos, Daniela; Duarte, Silvia; Vieira, Luís; Martins, Fátima; Machado, Jorge; Veríssimo, Vítor Cabral; Grau, Berta; Peralta-Santos, André; Neves, José; Caldeira, Margarida; Pestana, Mafalda; Fernandes, Cândida; Caria, João; Pinto, Raquel; Póvoas, Diana; Maltez, Fernando; Sá, Ana Isabel; Salvador, Mafalda Brito; Teófilo, Eugénio; Rocha, Miguel; Moneti, Virginia; Duque, Luis Miguel; E Silva, Francisco Ferreira; Baptista, Teresa; Vasconcelos, Joana; Casanova, Sara; Mansinho, Kamal.
Affiliation
  • Borges V; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Duque MP; Epidemiology and Statistics Division, Directorate-General of Health, Lisbon, Portugal.
  • Martins JV; Pathogen Dynamics Group, Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Vasconcelos P; Epidemiology and Statistics Division, Directorate-General of Health, Lisbon, Portugal.
  • Ferreira R; Public Health Emergency Centre, Directorate-General of Health, Lisbon, Portugal.
  • Sobral D; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Pelerito A; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • de Carvalho IL; Emergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Núncio MS; Emergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Borrego MJ; Emergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Roemer C; National Reference Laboratory for Sexually Transmitted Infections, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Neher RA; Biozentrum, University of Basel, Basel, Switzerland.
  • O'Driscoll M; Swiss Institute of Bioinformatics, Basel, Switzerland.
  • Rocha R; Biozentrum, University of Basel, Basel, Switzerland.
  • Lopo S; Swiss Institute of Bioinformatics, Basel, Switzerland.
  • Neves R; Pathogen Dynamics Group, Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Palminha P; National Reference Laboratory for Sexually Transmitted Infections, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Coelho L; National Reference Laboratory for Sexually Transmitted Infections, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Nunes A; National Reference Laboratory for Sexually Transmitted Infections, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Isidro J; National Reference Laboratory for Sexually Transmitted Infections, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Pinto M; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Santos JD; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Mixão V; Veterinary and Animal Research Centre (CECAV), Faculty of Veterinary Medicine, Lusófona University, Lisbon, Portugal.
  • Santos D; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Duarte S; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Vieira L; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Martins F; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Machado J; Technology and Innovation Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Veríssimo VC; Technology and Innovation Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Grau B; Technology and Innovation Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Peralta-Santos A; Technical Board, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Neves J; Department Coordination, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Caldeira M; Epidemiology and Statistics Division, Directorate-General of Health, Lisbon, Portugal.
  • Pestana M; Public Health Unit, ACES Cascais, ARSLVT, Cascais, Portugal.
  • Fernandes C; Epidemiology and Statistics Division, Directorate-General of Health, Lisbon, Portugal.
  • Caria J; Public Health Emergency Centre, Directorate-General of Health, Lisbon, Portugal.
  • Pinto R; ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Póvoas D; Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
  • Maltez F; Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
  • Sá AI; Comprehensive Health Research Centre (CHRC), Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa, Lisbon, Portugal.
  • Salvador MB; Serviço de Dermatovenereologia, Consulta de DST, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Teófilo E; Serviço de Dermatovenereologia, Consulta de DST, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Rocha M; Serviço de Dermatovenereologia, Consulta de DST, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Moneti V; Serviço de Dermatovenereologia, Consulta de DST, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Duque LM; Serviço de Doenças Infeciosas, Hospital de Curry Cabral, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • E Silva FF; Serviço de Doenças Infeciosas, Hospital de Curry Cabral, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Baptista T; Serviço de Doenças Infeciosas, Hospital de Curry Cabral, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Vasconcelos J; Instituto Gulbenkian de Ciência, Oeiras, Portugal.
  • Casanova S; Serviço de Doenças Infeciosas, Hospital de Curry Cabral, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Mansinho K; Unidade de Doenças Sexualmente Transmissíveis da Lapa, Lisbon, Portugal.
Nat Med ; 29(10): 2509-2517, 2023 10.
Article in En | MEDLINE | ID: mdl-37696933
ABSTRACT
Pathogen genome sequencing during epidemics enhances our ability to identify and understand suspected clusters and investigate their relationships. Here, we combine genomic and epidemiological data of the 2022 mpox outbreak to better understand early viral spread, diversification and transmission dynamics. By sequencing 52% of the confirmed cases in Portugal, we identified the mpox virus sublineages with the highest impact on case numbers and fitted them into a global context, finding evidence that several international sublineages probably emerged or spread early in Portugal. We estimated a 62% infection reporting rate and that 1.3% of the population of men who have sex with men in Portugal were infected. We infer the critical role played by sexual networks and superspreader gatherings, such as sauna attendance, in the dissemination of mpox virus. Overall, our findings highlight genomic epidemiology as a tool for the real-time monitoring and control of mpox epidemics, and can guide future vaccine policy in a highly susceptible population.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mpox (monkeypox) / Sexual and Gender Minorities Type of study: Prognostic_studies Limits: Humans / Male Country/Region as subject: Europa Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mpox (monkeypox) / Sexual and Gender Minorities Type of study: Prognostic_studies Limits: Humans / Male Country/Region as subject: Europa Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2023 Document type: Article Affiliation country:
...